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Background: Studies examining the prevalence, baseline characteristics and outcome of
patients admitted with Community Acquired Pneumonia (CAP) are not readily available in
Nigeria. This study aims to evaluate the management of CAP at a tertiary hospital in Nigeria
with a view to determining the prevalence, characteristics, severity and outcome of the
admitted patients.
Methods: We retrospectively collected data from 160 admitted patients with final diagnosis of
CAP who met the inclusion criteria. Data relating to their age, gender, clinical details, severity
assessment using CURB65 score, laboratory results, initial antibiotics prescribed, and outcome
(length of stay, hospital mortality) were collected. Descriptive statistics of demographic and
clinical variables were calculated and presented as frequencies, percentage, means, standard
deviation and range.
Results: CAP accounted for 2.5% of all medical admissions during the study period. The mean
age of the admitted patients was 52.9  18.98 years with about 35% of the patients being at
least 65years and above. Sputum culture, Fasting blood sugar and HIV screening were re-
quested for in 49(30.6%), 50(31.3%) 56(35%) patients respectively. None of the patients had
severity score documented on admission and only 32(20%) patients had severity score of 3
when calculated. Commonly prescribed antibiotics were a combination of intravenous cef-
triaxone and metronidazole. Hospital mortality rate was 11.9%
Conclusion: We suggest multicenter prospective studies to determine the prevalence and
burden of CAP in Nigeria. There is need for an improved assessment and appropriate use of
guidelines in the management of patients presenting with CAP.
ª 2010 Elsevier Ltd. All rights reserved.ny grant.
8037046243.
ahoo.co.uk, Cajetan.onyedum@unn.edu.ng (C.C. Onyedum).
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Management of CAP in Nigeria 299Introduction/background southeast Nigeria. The hospital has about 700 beds, withCommunity acquired pneumonia (CAP) is a leading infec-
tious disease requiring hospital admission in both developed
and developing countries including Nigeria. It is a common
cause of illness and death from infectious disease both in
western and developing countries1 and constitutes a major
burden on health care resources.
CAP is commonly defined as an acute infection of the
pulmonary parenchyma that is associated with symptoms of
acute infection accompanied by the presence of acute
infiltrate on a chest radiograph in a patient who has not
been hospitalized for more than 14 days before the onset of
the symptoms.2
A diagnosis of CAP is often made on clinical grounds and
patients are often started on treatment empirically before
the results of laboratory investigations are seen.
Previous studies in the USA showed an annual incidence
of about 3e5 cases per 1000 inhabitants among adults and
a mortality of about 5e15% among hospitalized patients.3,4
In a study in Ethiopia, mortality among admitted patients
with CAP was found to be 11%.5
Mortality due to CAP is often related to the severity of the
CAP and associated co existing illnesses like HIV infection,
DiabetesmellitusandChronicObstructivePulmonaryDisease.
Bacterial pneumonia is more frequent in HIV-infected
individuals than in the general population6 and there is often
high prevalence of HIV in CAP patients especially among
those with PTB suggesting it as a possible strong risk factor
for developing CAP.7 This becomes an important consider-
ation with regards to the high prevalence of HIV in a devel-
oping country like Nigeria. Despite the fact that several
scoring systems and guidelines have been developed by
international organisations to stratify risks and prognosis in
patients with CAP,8 these scoring systems have rarely been
used in most of our hospitals to identify those that are likely
going to be admitted.
In Nigeria, few data are available concerning the overall
incidence, prevalence, severity of illness, prognostic factors,
and choice of antibiotic treatment in community acquired
pneumonia which is a common condition requiring hospital
admission in Nigeria9 and those that had been done had
concentrated on the aetiological profile and were mostly
carried out in children.10
The aim of this study is to determine the hospital prev-
alence of CAP at a tertiary hospital during the study period,
to determine the characteristics of patients admitted, find
out the severity of the illness in those admitted using the
standardised CURB65 score, identify the initial antibiotics
prescription pattern and finally to determine the outcome of
the patients admitted. This study is hoped to contribute to
the documentation of the burden of CAP in our region and
identify the problems associated with the management of
this common but serious medical condition.
Methods
Setting
The studywasconductedat theUniversity ofNigeriaTeaching
Hospital, Ituku Ozalla Enugu Nigeria, a tertiary hospital ina workforce of more than 5000 staffs.
The hospital receives patients from Enugu and other
parts of the southeast region of Nigeria comprising of five
states.
Majority of the patients were admitted through the acci-
dent and emergency unit of the hospital, and were usually
seen by the emergency room doctors and reviewed by
medical registrars on call before admission to the medical
wards.
Study design and patients (patients and methods)
Datawere retrieved retrospectively from case notes and drug
charts of adult patients aged 18 years and above with
a provisional clinical diagnosis of Pneumonia admitted into
the medical wards of the UNTH between 1st July, 2003 and
30th June, 2008. Patient’s case notes were included for the
final analysis if they had a final diagnosis of pneumonia with
new infiltrates on chest radiograph and presented acutely
with at least two compatible clinical features: cough, sputum
production, breathlessness, pleuritic chest pain, haemopt-
ysis, fever, headache, and signs consistentwithpneumoniaon
chest auscultation.11 They would not have been admitted
to the hospital or health care facility in the last 14 days prior
to presentation.2 Patients who did not have chest ray
during the admission and those that developed symptoms
more than 48 h following admission were excluded. Patients
were also excluded if the diagnosis was changed soon after
admission.
The study was approved by the ethics committee of the
University Teaching Hospital Enugu.
Data were collected with respect to their age, gender,
clinical details, co-existing illness, severity, laboratory
requests and results, antibiotics used, previous antibiotics
use and outcome (hospital length of stay, hospital mortality).
Disease severity was assessed retrospectively by calcu-
lating the CURB65 score8,12 based on recorded clinical
parameters on the assumption that, unless otherwise
stated, that the patient was not confused. Severe disease
was defined as score of 3.12
Data were analysed using SPSS version 15.0 for windows.
Descriptive statistics of demographic and clinical variables
calculated included frequencies, percentage, means,
standard deviation and range.
Results
249 admissions were due to Pneumonia out of a total 6387
patients (4175males and 2212 females) during the period
under review. 230 case notes were retrieved, out which 160
cases qualified for a final diagnosis of Community Acquired
Pneumonia and were eventually studied. This gave a
hospital prevalence of about 2.5% among medical admis-
sions during the study period.
The baseline characteristics showed that 88 (55%) of the
patients were males. The mean age of the patients was
52.9  18.98 years with range from the youngest of 25 years
to the oldest patient of 80 years of age.
The most common symptoms were fever (75%) cough
(71.3%) breathlessness (55%) and chest pain (50%).
Table 2 Patients characteristics, Clinical assessment
findings and outcome measures of patients with CAP
(N Z 160).
Baseline characteristics Mean (SD), range or n (%)
Age n (%) 52.9 (18.98), 25e80
Age (65) n (%) 56 (35)
Male n (%) 88 (55)
Female 72 (45)
Presenting symptoms
Cough n (%) 114 (71.3)
Sputum n (%) 96 (60)
Fever n (%) 120 (75)
Breathlessness n (%) 88 (55)
Chest Pain n (%) 80 (50)
Myalgia 8 (5)
Headache n (%) 24 (15)
Diarrhoea n (%) 8 (5)
Vomiting n (%) 24 (15)
Clinical parameters
Systolic blood pressure n (%) 128.68 (26.44), 90e180
Diastolic blood Pressure n (%) 76 (16.61), 50e110






Chest X-ray n (%) 160 (100)
Sputum Culture n (%) 49 (30.6)
ZN Stain n (%) 51 (31.9)
Blood Culture n (%) 13 (8.1)
SEUC n (%) 2 (1.3)
Haemoglobin n (%) 128 (80)
WBC n (%) 120 (75)
HIV Screening n (%) 56 (35)
Fasting Blood Sugar n (%) 50 (31.3)
Laboratory results
Hb (g/dl) 10.56 (2.43), 6e14
300 C.C. Onyedum, J.C. ChukwukaSputum culture was requested for in 49(30.6%) patients
while Serum Electrolytes, Urea and creatinine were done in
only two patients. Fasting blood sugar was done in 50 (31.3%)
of cases.
Fifty six patients (35%) were screened for HIV and 48
patients representing 30% of the whole patients studied and
85.7% of those screened for HIV were positive for HIV
antibodies.
Co-existing illnesses include COPD (10%), Diabetes Mel-
litus (10%), Previous Cerebrovascular Disease (10%), HIV
coinfection (87.5% of those screened) and Asthma (3.1%).
Sixty two of the patients representing 38.8% had at least
one co morbidity or the other.
Fifty six of the patients (35%) of the patients were 65
years and above.
None of the patients studied had disease severity score
documented. Thirty two patients (20% of the patients)
however had severe pneumonia with CURB65 score of 3 and
above when calculated retrospectively.
Sixteen patients (10%) had used antibiotics before presen-
tation. Commonly prescribed antibiotics initially on admission
were intravenous ceftriaxone combined with metronidazole
in 52.5% of cases followed by Intravenous ceftriaxone alone
in 20.6% of cases (Table 1). Fourteen patients (8.8%) were
commenced on oral antibiotics while on admission. Eight
patients were current smokers.
Hospital length of stay during the study period ranged
from the shortest stay of two days to the longest stay of 21
days with the mean duration of stay of 10.5  5.2 days
(Table 2).
Nineteen of the patients (11.9%) died while on admission
in the hospital while the rest were discharged. Ten of the
patients that died (52.6%) had co morbidities while six of
those that died (31.6%) were HIV positive.
Discussion
Comprehensive Studies examining the prevalence, baseline
characteristics and outcome of patients with CAP are not
readily available inNigeria9 and those that had beendone had
concentrated on the aetiological profile and were mostly
carried out in children.10 To the best of our knowledge, this isWBC 7160 (3343.38), 2300e13000
FBS (mmol/l) 6.2 (2.2) 3.3e13.1
Positive HIV screening 48 (30%) 85.7% of
those screened
Co-existing illnesses
COPD n (%) 16 (10)
Asthma n (%) 5 (3.1)
DM n (%) 16 (10)
Cerebrovascular Disease n (%) 16 (10)
HIV n (%) 48 (30)
At least one co morbidity (%) 62 (38.8)
Current Smoker n (%) 8 (5%)
Previous antibiotics used n (%) 16 (10%)
Outcome measures
Died during admission n (%) 19 (11.9)
Discharged n (%) 141 (88.1)
Hospital length of stay (days) 10.5 (5.23), 2e21




IV Ceftriaxone þ IV
Metronidazole
84 (52.5)
IV Ceftriaxone only 33 (20.6)
IV ampiclox þ IV Metronidazole 3 (1.9)
IV augmentin only 8 (5)
IV Augmentin þ IV
Ceftriaxone þ Metronidazole
8 (5)
IV Ciprofloxacin 9 (5.6)






Management of CAP in Nigeria 301the first study in the South East Nigeria to characterise adult
patients admitted with CAP and to show their outcome.
The main findings of this study were: (1) More male
patientswith CAPwere admitted; (2) Patients above 65 years
of age constituted 35% of those admitted. (3) About 80% of
the patients admitted for CAP at this center may not have
needed admission as they had non severe pneumonia with
CURB65 severity score of 0e2; (4) Co existing illnesses were
common in patients with CAP and HIV positivity was very
common occurring in 87.5% of those that were screened; (5).
Most patients admitted did not have detailed laboratory
work up like sputum culture, blood culture, HIV screening,
fasting blood sugar and SEUC; (6) Medical Registrars who saw
the patients initially tended to prescribe a combination of
a intravenous cephalosporin with metronidazole; (7)
Hospital Mortality rate among those studied was 11.9% and
more than half of the patients that died had co morbidities.
The major limitation of this study was that it was a retro-
spective study and was not able to assess carefully the
aetiological organisms, assess the severity scores in details
and unable to get full information on other outcome details
like the need for ICU admission, need for mechanical venti-
lation and 30 day mortality and the actual cause of the
patients deaths due to poor documentation in the patients
case notes. Also, this study was done in tertiary referral
hospital, so whatever was found here might just be the tip of
iceberg.
This study showed that more males were admitted with
pneumonia as has been reported in previous studies.1,7,8
Elderly people were more affected with about 35% of
them being above 65 years of age, this is not surprising as
this shows that old people tend to have more attacks of
severe CAP and are more likely to be admitted during the
cause of the illness.
Majority of the patients did not have detailed laboratory
workup that would have been useful both in severity
assessment and the holistic management of these patients.
It is quite revealing that less than half of the patients had
requests for the investigations that will reveal the organ-
isms responsible for the infection (sputum culture and
staining for mycobacterium). This calls for a critical review
of the assessment of these patients at and during admission
considering the importance of identification of the aetio-
logical agents of the CAP more so when it has been shown in
previous studies7 that Tuberculosis prevalence among CAP
patients is high and have very important implications in
their management.
Risk factors for developing CAP like HIV status and Dia-
betes Mellitus were not assessed for in the majority of the
patients studied. At least 38.8% of the total number of
patients had co existing illnesses like HIV, COPD, Diabetes
Mellitus, Asthma, previous Cerebrovascular disease etc.
This is higher than what was obtained in another study in
western Nigeria where the prevalence of comorbidity was
about 25%.13 The higher rate of co morbidity in this present
study could be explained by the inclusion of HIV infection as
a comorbidity which was not considered in the other study.
Less than half of these patients were screened for HIV
infection, however a high prevalence of 85.7% of those
screened and 30% of the total population of patients
studied were shown to be HIV positive. The 30% prevalence
of HIV positivity among the patients studied is higher than17.4% obtained in a previous study in Nigeria.7 The high
prevalence of HIV positivity (85.7%) among those screened
for HIV could be due to the fact that the screening tests
were done only for patients with high risk factors and those
with classical features of advancing HIV infection. It is
important that HIV screening is done routinely in CAP
patients because CAP patients with HIV infection are more
likely to present with severe symptoms14 and the fact that
bacterial pneumonia may accelerate the progression of HIV
disease.15
None of the patients studied had the CURB65 score
documented in their hospital case notes. Poor or no
documentation of severity assessment scores for CAP before
admission is not peculiar to our region as it has been reported
in some previous studies done even in developed societies
with advanced health care facilities and manpower.16,17
The 5% prevalence rate of smoking among the patients
with CAP was lower than the smoking prevalence in
Nigeria,18,19 this could be explained by poor documentation
in the case notes of patients because of the retrospective
nature of the study and the fact that when patients
perceive that their illnesses may be related to smoking,
they tend to deny the history of smoking to avoid blame
from their relatives.
A significant percentage of the patients (80%) could have
been considered for outpatients care based on the retro-
spectively calculated CURB65 scores of less than 3 and
managed in the community possibly with oral antibiotics
since they had nonsevere CAP thereby saving health care
resources. It is necessary to point out that poor documenta-
tion may have made it difficult to retrospectively calculate
theCURB65 score as inmany cases the conscious levelwas not
documented and only two of thewhole patients reviewedhad
records of their serumeurea levels. We posit that attending
physicians should be trained in the use of pneumonia severity
assessment tools to help in stratifying these patients initially
and avoiding unnecessary admissions which invariably put
a lot of stress on the scarce health care resources.
The initial choice of antibiotics which included intra-
venousmetronidazole in majority of cases did not show that
the attending medical officers were empirically treating for
the common organisms known to cause CAP in this sub
region. This prescription pattern does in no way reflect the
presence of more nonbacterial pneumonia in our environ-
ment. This is rather surprising and disturbing more so when
this is happening in a referral center. Though we are not
aware of any national guidelines for treating CAP, Physi-
cians need to constantly update themselves on current
management of common but severe illness like CAP.
The hospital mortality rate of 11.9% found in this study
was comparable to the 11% obtained in a study in Ethiopia5
but higher than what has been found in Hong Kong,8 Guinea
and France.1 The mortality rate found in this study was for
only during the admission period and could be higher than
what was obtained in the previous studies that looked at 30
day mortality which was however difficult to extrapolate
from the case notes because of poor documentation. It is
equally nice to remember that in the previous studies with
lower mortality, patients with HIV infection were excluded
unlike in this study.
In conclusion, we suggest that multicenter prospective
studies should be designed and done in Nigeria to enable
302 C.C. Onyedum, J.C. Chukwukaproper documentation of the prevalence and the burden of
CAP in Nigeria. Severity assessment scores for CAP should
be of importance in the initial assessment of patients with
CAP to prevent unnecessary admissions.
Assessment for co morbidities like HIV co infection and
Diabetes Mellitus should be done as majority of the patients
are HIV positive and tend to have co morbidities and this
could have far reaching implication in their management.
Also physician’s guidelines on the use of appropriate anti-
biotics in CAP should be introduced as part of continuing
medical education on national and institutional levels to
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